Retail Press Releases
SEE OTHER BRANDS

News on retail in the world

Retail Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Retail Press Releases.

Press releases published on July 22, 2025

Majestic Ideal Holdings Limited Announced Closing of Initial Public Offering

Majestic Ideal Holdings Limited Announced Closing of Initial Public Offering

NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) -- Majestic Ideal Holdings Limited (Nasdaq: MJID) (the “Company”), a provider of SCM services in the apparel industry delivering one-stop solution, today announced the closing of its initial public offering (the “ …

Outlook Therapeutics Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference

Outlook Therapeutics Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference

Video webcast now available on-demand ISELIN, N.J., July 22, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, …

GRI Bio Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference

GRI Bio Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference

– Video webcast now available on-demand LA JOLLA, CA, July 22, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the …

Palisade Bio Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference

Palisade Bio Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference

– Video webcast now available on-demand Carlsbad, CA, July 22, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company focused on developing and advancing novel …

Oriental Rise Holdings Limited Announces Pricing of $6.9 Million Public Offering

Oriental Rise Holdings Limited Announces Pricing of $6.9 Million Public Offering

NINGDE, China, July 22, 2025 (GLOBE NEWSWIRE) -- Oriental Rise Holdings Limited (Nasdaq: ORIS) (“Oriental Rise” or the “Company”), an integrated supplier of white- and black-tea products in mainland China, today announced the pricing of its public offering …

Sysco celebrates expansion with grand opening of Sysco Tampa Bay

Sysco celebrates expansion with grand opening of Sysco Tampa Bay

PLANT CITY, Fla., July 22, 2025 (GLOBE NEWSWIRE) -- Today, Sysco Corporation, the leading global foodservice distribution company, is inviting media to attend a press conference and tour celebrating the grand opening of our newest distribution center, …

HIMS DEADLINE: Lose Money on Hims & Hers Health, Inc. (NYSE:HIMS)? You may have been Affected by Fraud and are Urged to Contact BFA Law by August 25

HIMS DEADLINE: Lose Money on Hims & Hers Health, Inc. (NYSE:HIMS)? You may have been Affected by Fraud and are Urged to Contact BFA Law by August 25

NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …

OLO SHAREHOLDER ALERT: Current Shareholder of Olo Inc. (NYSE:OLO)? Contact BFA Law about its Investigation into the $10.25 Merger Price

OLO SHAREHOLDER ALERT: Current Shareholder of Olo Inc. (NYSE:OLO)? Contact BFA Law about its Investigation into the $10.25 Merger Price

NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …

FTRE DEADLINE: Lose Money on Fortrea Holdings Inc. (NASDAQ:FTRE)? You may have been Affected by Fraud and are Urged to Contact BFA Law by August 1

FTRE DEADLINE: Lose Money on Fortrea Holdings Inc. (NASDAQ:FTRE)? You may have been Affected by Fraud and are Urged to Contact BFA Law by August 1

NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …

CNC DEADLINE: Lose Money on Centene Corporation (NYSE:CNC)? You may have been Affected by Fraud and are Urged to Contact BFA Law by September 8

CNC DEADLINE: Lose Money on Centene Corporation (NYSE:CNC)? You may have been Affected by Fraud and are Urged to Contact BFA Law by September 8

NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …

RDDT DEADLINE: Lose Money on Reddit, Inc. (NYSE:RDDT)? You may have been Affected by Fraud and are Urged to Contact BFA Law by August 18

RDDT DEADLINE: Lose Money on Reddit, Inc. (NYSE:RDDT)? You may have been Affected by Fraud and are Urged to Contact BFA Law by August 18

NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …

SRPT DEADLINE: Lose Money on Sarepta Therapeutics, Inc. (NASDAQ:SRPT)? You may have been Affected by Fraud and are Urged to Contact BFA Law by August 25

SRPT DEADLINE: Lose Money on Sarepta Therapeutics, Inc. (NASDAQ:SRPT)? You may have been Affected by Fraud and are Urged to Contact BFA Law by August 25

NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …

BRBR LOSS ALERT: Lose Money on BellRing Brands, Inc. (NYSE:BRBR)? You may have been Affected by Fraud and are Urged to Contact BFA Law

BRBR LOSS ALERT: Lose Money on BellRing Brands, Inc. (NYSE:BRBR)? You may have been Affected by Fraud and are Urged to Contact BFA Law

NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …

AAPL DEADLINE: Lose Money on Apple Inc. (NASDAQ:AAPL)? You may have been Affected by Fraud and are Urged to Contact BFA Law by August 19

AAPL DEADLINE: Lose Money on Apple Inc. (NASDAQ:AAPL)? You may have been Affected by Fraud and are Urged to Contact BFA Law by August 19

NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …

RXST LOSS ALERT: Lose Money on RxSight, Inc. (NASDAQ: RXST)? You may have been Affected by Fraud and are Urged to Contact BFA Law

RXST LOSS ALERT: Lose Money on RxSight, Inc. (NASDAQ: RXST)? You may have been Affected by Fraud and are Urged to Contact BFA Law

NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …

Allesin Introduces Prestige Motorized Roller Shades, Enhancing Smart Shading Access for U.S. Homes

Allesin Introduces Prestige Motorized Roller Shades, Enhancing Smart Shading Access for U.S. Homes

NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) -- Smart home integration is rapidly moving beyond lights and thermostats. Allesin, a brand focused on accessible smart shading solutions, is expanding its U.S. product lineup with the launch of the Allesin Prestige …

Neuronetics to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call

Neuronetics to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call

MALVERN, Pa., July 22, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, …

Comscore to Announce Second Quarter 2025 Financial Results

Comscore to Announce Second Quarter 2025 Financial Results

RESTON, Va., July 22, 2025 (GLOBE NEWSWIRE) -- Comscore, Inc. (Nasdaq: SCOR), a trusted partner for planning, transacting and evaluating media, today announced that it plans to hold a conference call to discuss its financial results for the second quarter …

Day One to Report Second Quarter 2025 Financial Results Tuesday, August 5, 2025

Day One to Report Second Quarter 2025 Financial Results Tuesday, August 5, 2025

BRISBANE, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life- …

Veru to Participate in the 2025 BTIG Virtual Biotech Conference

Veru to Participate in the 2025 BTIG Virtual Biotech Conference

MIAMI, FL, July 22, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced that the …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions